QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
OTCMKTS:CDXI

Cardax (CDXI) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CDXI stock logo

About Cardax Stock (OTCMKTS:CDXI)

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia; and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax, Inc. is based in Honolulu, Hawaii.

CDXI Stock News Headlines

Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Cardax, Inc. (CDXI)
CDXI After-Hours Quotes
Cardax Inc. makes several moves to reduce costs
Cardax Inc. suspends SEC reporting obligations
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Cardax Voluntarily Suspends SEC Reporting Obligations
See More Headlines
Receive CDXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardax and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CDXI
Employees
10
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.09
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. David G. Watumull (Age 74)
    Chairman & CEO
    Comp: $214.96k
  • Mr. David M. Watumull (Age 42)
    COO & CFO
    Comp: $162.11k
  • Mr. Gilbert Shin
    Vice President of Retail Sales & Marketing

CDXI Stock Analysis - Frequently Asked Questions

How do I buy shares of Cardax?

Shares of CDXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CDXI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners